Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06336057 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mentalizating in Adults Suffering from Narcolepsy Type 1.

Study acronym: NARCOMENTAL
StatusUnknown
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Primary completion date changed from estimate of Apr 2024 to May 17, 2024 Start date changed from estimate of Apr 2024 to May 17, 2024 · Secondary endpoints: details revised at 2 of 4 entriesv3 Show 2 more changesShow less
    • Start date changed from estimate of Apr 2024 to May 17, 2024
    • Secondary endpoints: details revised at 2 of 4 entries
  3. Trial status: Not Yet Recruiting to Recruiting Secondary endpoints: details revised at 2 of 4 entries · Study site revisedv2 Show 2 more changesShow less
    • Secondary endpoints: details revised at 2 of 4 entries
    • Study site revised

    See this version in full on ClinicalTrials.gov ↗

  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main objective is to examine the potential mentalization impairments affecting a population suffering from narcolepsy type 1. Indeed, the hypothesis of this research is that mentalization could be impaired in narcoleptic patients.
Trial Details
NCT Number NCT06336057
Lead Sponsor University Hospital, Toulouse
Conditions Narcolepsy Type 1
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov